India’s medtech sector is poised for growth with the launch of MedArtha Capital, a Rs 1,000 crore fund. Spearheaded by industry veterans, it aims to back 10-12 high-growth companies, boosting ‘Make in India’ and reducing import reliance. The government may invest Rs 500 crore, supporting innovation in critical medical devices.
No valid response from Gemini.
